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Introduction
BEST was developed by a board of key stakeholders of
European community group representatives, People
Living with HIV (PLWHIV), researchers, clinicians,
nurses and medical organisations, representing 6 Eur-
opean countries, (UK, Germany, France, Italy, Portugal
and Spain). BEST focuses on empowering PLWHIV to
make decisions about starting Antiretroviral Therapy
(ART) as per current EACS Guidelines. It aims to edu-
cate tested, but not treated PLWHIV on the benefits of
starting ART according to current guidelines to improve
their long-term health and quality of life.
Rationale
In Europe many people start ART with a CD4 count
lower than current guidelines recommend, with asso-
ciated increased morbidity and mortality [1]. Lack of
understanding of guidelines, and ineffective communica-
tion between PLWHIV and their healthcare profes-
sionals (HCPs) may delay the commencement of ART
in PLWHIV.
Programme development
The programme was developed by an Advisory Board,
and Review Committee of HCPs and community mem-
bers, with material content at the Boards’ discretion. It
is organised and funded by Bristol-Myers Squibb and
Gilead Sciences.
Materials
The toolkit contains 5 presentation sections to facilitate
discussion around; Preparing and Readiness to Start ART:
When to Start Treatment: The Rationale; Reasons to start
at a CD4 of 350 or above; Building the Best Relationship
with Your HIV Clinic and HIV and ART: Questions and
Answers. A 6th section, ‘Running Workshops’ provides
information on running workshops, facilitating audience
participation and evaluation. It is intended for use by
advocacy workers and/or healthcare workers.
Progress to date
BEST was launched at EACS 2009 to a group of mainly
community advocacy workers from 6 European countries.
Evaluation showed that the materials and workshop
format were well received and addressed an unmet need
in the countries represented. BEST was rolled out locally
in the 1st half of 2010 in 6 pilot countries, where it has
had considerable success. Feedback and evaluation from
the national rollout will be provided in detail in this poster
presentation.
Future plans
We hope BEST will result in more PLWHIV starting
ART at the recommended optimum time, possibly deter-
mined by prospective surveillance or audit at a local
level. Evaluation systems will enable the BEST Advisory
Board to respond to the changing needs of users; and to
develop appropriate new materials. Regular updates to
BEST are planned every 6 months.
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